Screener
Amylyx Pharmaceuticals, Inc. AMLX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Amylyx Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:04 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336682
FAQ
- What is Amylyx Pharmaceuticals, Inc.'s net income?
- Amylyx Pharmaceuticals, Inc. (AMLX) reported net income of -$43.42M in Q2 2026.
- How has Amylyx Pharmaceuticals, Inc.'s net income changed year-over-year?
- Amylyx Pharmaceuticals, Inc.'s net income decreased by 4.8% year-over-year, from -$41.44M to -$43.42M.
- What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s net income?
- Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s net income has grown at a 13.3% compound annual growth rate (CAGR), from -$87.93M to -$144.74M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Amylyx Pharmaceuticals, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude